immunization

(redirected from Active immunization)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Wikipedia.

immunization:

see immunityimmunity,
ability of an organism to resist disease by identifying and destroying foreign substances or organisms. Although all animals have some immune capabilities, little is known about nonmammalian immunity.
..... Click the link for more information.
; vaccinationvaccination,
means of producing immunity against pathogens, such as viruses and bacteria, by the introduction of live, killed, or altered antigens that stimulate the body to produce antibodies against more dangerous forms.
..... Click the link for more information.
.

Immunization

 

a method of creating artificial immunity in man and animals. Active and passive immunization are distinguished.

Active immunization involves injecting antigens into the body. The commonest form of active immunization is vaccination—that is, the use of vaccines, preparations obtained from microorganisms (bacteria, rickettsias, and viruses) or their metabolic products (toxins) for the specific prevention of infectious diseases in man and animals. Active immunization is produced by applying a preparation (for example, a vaccine) to the skin, by injecting it subcutaneously, intracutaneously, intramuscularly, intraperitoneally, or intravenously, or by administering it orally or by inhalation. The dose of the vaccine influences the efficacy of immunization (to a certain limit, the immunizing effect increases with increasing dosage; hence, optimum doses, determined experimentally, are used). The immunization schedule, the reactivity of the organism, and the quality of the preparation are important factors.

The antigen is usually injected several times to create immunity. A second immunization (reimmunization) is carried out no sooner than one or two weeks after the first, so that the antibodies and antibody-forming cells will not be neutralized by excess antigen and thereby reduce the strength of the growing immunity. Immunizations repeated at intervals of several months or years are very effective.

Antigens adsorbed on aluminum hydroxide, phosphates, or alums or mixed with mineral oils are frequently used for purposes of immunization. These substances, called adjuvants, intensify the immunizing effect of the antigen, bring about its gradual absorption from the injection site, and stimulate nonspecific antibody formation. Active immunization produces prolonged immunity (for a year or more) through the formation of specific antibodies and immune cells, and through the stimulation of nonspecific immunity factors.

Passive immunization is produced by injecting serum or serum fractions from the blood of immune animals and persons subcutaneously, intramuscularly, or, in certain emergencies, intravenously. Such preparations contain preformed antibodies, which neutralize toxin, inactivate the causative agent, and prevent the agent from spreading. Passive immunization creates temporary immunity (to a month). It is used to prevent disease in cases of contact with a source of infection (measles, diphtheria, tetanus, gas gangrene, plague, anthrax, influenza [seroprophylaxis] or, if the disease has already set in, to mitigate its course [serotherapy]). Sometimes combined immunization is used: first the immune serum is injected to help the patient cope with the infection, and then the vaccine is introduced in order to create a more stable immunity.

Homologous serums (that is, serums obtained from human blood) are preferred for the seroprophylaxis of infections in man. These serums generally do not provoke allergic reactions and are effective in infections (measles, infectious hepatitis) for which appropriate serums cannot be obtained from animals. Heterologous serums, or those obtained from animals (horse serum is used most frequently), may cause sensitization and provoke allergic reactions (anaphylactic shock, serum sickness). The use of heterologous serums is being curtailed. Seroprophylaxis with protein fractions (gamma globulin, polyglobulin and so forth) of human venous, placental, and abortion blood is commonly used instead.

Immunization is widely used against animal diseases caused by pathogenic viruses (foot-and-mouth disease, cattle plague), rickettsias (hydropericarditis), and bacteria (anthrax, blackleg, brucellosis). It is carried out in a planned regime, with account taken of the local conditions and the particular characteristics of the diseases.

A. KH. KANCHURIN and N. V. MEDUNITSYN

immunization

[‚im·yə·nə′zā·shən]
(immunology)
Rendering an organism immune to a specific communicable disease.
References in periodicals archive ?
Active immunization of heifers against luteinizing hormone-releasing hormone, human chorionic gonadotropin and bovine luteinizing hormone.
In spite of active immunization with recombinant DNA vaccine, some patients became infected with HBV infection.
The vaccine is also indicated in adults 50 years of age and older for active immunization for the prevention of pneumonia and invasive disease caused by the 13 Streptococcus pneumoniae serotypes contained in the vaccine (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F).
In a study from India, in children with ALL who received active immunization combined with specific hepatitis B immunoglobulin during intensive chemotherapy, infection rate was 17%, and in the group who received active immunization combined with interferon, the infection rate was 59%.
About Quadracel Vaccine Indication Quadracel vaccine is given for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis.
The new vaccine is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitides serogroups A, C, Y, and W-135.
Prevenar 13 also is available through the World Health Organization (WHO) pre-qualification program for active immunization of infants and young children, as well as adults 50 years and older.
Novartis announced today that the US Food and Drug Administration (FDA) has granted accelerated approval of Bexsero(Meningococcal Group B Vaccine recombinant, adsorbed ) for active immunization to prevent invasive meningococcal disease caused by serogroup B (also known as meningitis B) in adolescents and young adults from 10 years through 25 years of age.
Fluzone Intradermal Quadrivalent vaccine is indicated for adults 18 through 64 years of age for active immunization for the prevention of influenza ("the flu") caused by influenza A subtype viruses and type B viruses contained in the vaccine.
To calculate the market size, the report considers revenue generated through the sales of various vaccines intended for active immunization against different serogroups of hepatitis B virus.
The Food and Drug Administration has approved a new smallpox vaccine, ACAM2000, for active immunization against smallpox in individuals determined to be at high risk for smallpox infection.
Prevenar 13 was previously prequalified for active immunization of infants and children from six weeks through 5 years of age against invasive pneumococcal disease, pneumonia and otitis media in August 2010.